UnitedHealth Group continually forecasts and manages its cash, investments, working capital balances and capital structure to meet the short-term and long-term obligations of its businesses while maintaining liquidity and financial flexibility, and uses these cash flows to expand through acquisitions, reinvest through capital expenditures, repay debt and return capital to stockholders. The company leverages core competencies in advanced technology, health care data, information and intelligence, and clinical care management and coordination to meet system demands; frequently evaluates and adjusts its market approaches—considering product positioning, competitive and regulatory factors—to balance growth and profitability; and endeavors to mitigate medical cost pressures with targeted medical management. It works collaboratively with clinicians to leverage data and analytics, invests in new clinical and administrative information and management systems to support coordinated care and service innovation, and intensifies medical and operating cost management by reconfiguring care provider networks, adjusting member benefits, modifying premium structures and making localized offering decisions to preserve performance under regulatory and funding pressures. The company continues to dedicate substantial resources to advance quality scores and star ratings, strengthen local market programs and improve operational efficiency. In the management of risk, UnitedHealth estimates obligations for incurred but not reported medical services using actuarial completion factors and per-member-per-month trend factors, re-examines and adjusts these estimates as new information becomes available, and recognizes that actual claim payments may differ materially, affecting medical costs and profitability. In managing Medicare revenues, the company estimates risk adjustment payments based on submitted and expected data, acknowledging that actual CMS adjustments may be favorable or unfavorable to revenue and net earnings. Its goodwill impairment testing employs multi-step discounted cash flow analyses, incorporating assumptions about free cash flow forecasts, capital requirements, income taxes, long-term growth rates and discount rates aligned with internal plans; its finite- and indefinite-lived intangible assets are reviewed for impairment when indicators arise. The investment portfolio is continually monitored for other-than-temporary impairments, with securities below cost reviewed for credit and market factors, intent to sell and issuer prospects, and the company recognizes that changing interest rates or market conditions may require portfolio reconfiguration to preserve integrity and performance under economic perturbations.